Compare · ASTH vs BAH
ASTH vs BAH
Side-by-side comparison of Astrana Health Inc. (ASTH) and Booz Allen Hamilton Holding Corporation (BAH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASTH and BAH operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- BAH is the larger of the two at $8.88B, about 4.8x ASTH ($1.87B).
- BAH has been more active in the news (17 items in the past 4 weeks vs 6 for ASTH).
- BAH has more recent analyst coverage (25 ratings vs 7 for ASTH).
- Company
- Astrana Health Inc.
- Booz Allen Hamilton Holding Corporation
- Price
- -
- -
- Market cap
- $1.87B
- $8.88B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2010
- News (4w)
- 6
- 17
- Recent ratings
- 7
- 25
Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital, mission operations, and cyber solutions to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations. It also provides analytics services, which focuses on delivering transformational solutions in the areas of artificial intelligence, such as machine learning, deep learning; data science, such as data engineering and predictive modeling; automation and decision analytics; and quantum computing. In addition, the company designs, develops, and implements solutions built on contemporary methodologies and modern architectures; delivers engineering services and solutions to define, develop, implement, sustain, and modernize complex physical systems; and provides cyber risk management solutions, such as prevention, detection, and cost effectiveness. Booz Allen Hamilton Holding Corporation was founded in 1914 and is headquartered in McLean, Virginia.
Latest ASTH
- Director Schmidt David exercised 20,000 shares at a strike of $5.00 and returned $771,800 worth of shares to the company (20,000 units at $38.59) (SEC Form 4)
- New insider Vong John claimed ownership of 22,426 shares (SEC Form 3)
- Former Officer Sobotka Glenn returned 11,793 shares to the company, decreasing direct ownership by 84% to 2,246 units (SEC Form 4)
- SEC Form 10-Q filed by Astrana Health Inc.
- Astrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Astrana Health, Inc. Reports Second Quarter 2026 Results
- Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call
- Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth
- Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year
Latest BAH
- Booz Allen Hamilton Holding Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Booz Allen Completes Acquisition of Ultra I&C Mission Solutions Business
- VP, PAO & Controller Metzfield Dennis sold $36,544 worth of shares (469 units at $77.92), decreasing direct ownership by 9% to 4,989 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Booz Allen Hamilton Holding Corporation
- SEC Form SCHEDULE 13G filed by Booz Allen Hamilton Holding Corporation
- Director Read Rory P was granted 4,689 shares, increasing direct ownership by 47% to 14,574 units (SEC Form 4)
- Director Jewett Ellen was granted 3,058 shares, increasing direct ownership by 19% to 19,149 units (SEC Form 4)
- Director Dial Debra L. was granted 3,058 shares, increasing direct ownership by 101% to 6,087 units (SEC Form 4)
- Director Gaumond Mark E. was granted 3,805 shares, increasing direct ownership by 6% to 66,779 units (SEC Form 4)
- Director Nolan Ryan was granted 4,689 shares, increasing direct ownership by 582% to 5,494 units (SEC Form 4)